A $1.6M pre-seed round has landed at Ayati Devices Pvt. Ltd., with Inflexor Ventures writing the check. The Mumbai-based company, incorporated in February 2019, is building a novel diabetic foot screener designed to help clinicians cut down on screening time without sacrificing accuracy.
The device also gives neuropathic patients a way to monitor their condition on their own, which could feed more useful data back into their treatment plans. Ayati's focus sits squarely in the diabetes care space, where early detection of foot complications can make a meaningful difference. The fresh capital from Inflexor Ventures will help push the product forward, though the company hasn't detailed specific next steps.
